Phase 2 trial of autologous MPC therapy reports
Author: Michael
Targeting clinical trials in metabolic dysfuncti
Function announced the appointment of Ziad Sultan
ProMIS Neurosciences announced a peer‑reviewed
GenSight Biologics announced that GS010/LUMEVOQ h
Fountain Life said that its Executive Health Memb
AltPep Corporation revealed new preclinical findi
Early bird pricing opens as the sector prepares
Hevolution documents rising public expectation,
Approach aims to identify multiple disease-drive